載入...
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort
BACKGROUND: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc cohort. METHODS: Details on immunosuppressive/antiprolifera...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7092571/ https://ncbi.nlm.nih.gov/pubmed/32293545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-2140-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|